HIGHTIDE
Dead / Abandoned — Abandoned — incomplete response (as of 06 Nov 2023)
What this means for you
This application is over — abandoned 29 Sept 2023. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88047279
- Mark type
- Stylized text
- Filed
- 21 Jul 2018
- Published for opposition
- 01 Sept 2020
- Abandoned
- 29 Sept 2023
- Attorney of record
- Yin Philip Zhang
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for use in treatment of diseases, namely, metabolic diseases, autoimmune diseases, cardiovascular diseases, neurodegenerative diseases, cancers and tumors; pharmaceutical preparations for use in treatment of hematological, diabetic, muscular, rheumatic, immunological, respiratory, central nervous system, bone, digestive, gastrointestinal, and liver diseases; pharmaceutical preparations for use in treatment of inflammatory bowel disease (IBD), namely, Crohn's disease and ulcerative colitis (UC); pharmaceutical preparations for use in treatment of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH)
Owner
- Shenzhen HighTide Biopharmaceutical, Ltd., Shenzhen, Guangdong, CN
- Shenzhen HighTide Biopharmaceutical, Ltd., Shenzhen, Guangdong, CN
Prosecution history
- 06 Nov 2023 — ABANDONMENT NOTICE MAILED - INCOMPLETE RESPONSE
- 06 Nov 2023 — ABANDONMENT NOTICE MAILED - INCOMPLETE RESPONSE
- 06 Nov 2023 — ABANDONMENT - INCOMPLETE RESPONSE
- 10 Oct 2023 — DIVISIONAL PROCESSING COMPLETE
- 28 Sept 2023 — DIVISIONAL REQUEST RECEIVED
- 02 Oct 2023 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 29 Sept 2023 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 28 Sept 2023 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 28 Sept 2023 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 28 Sept 2023 — TEAS REQUEST TO DIVIDE RECEIVED
- 28 Jun 2023 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 28 Jun 2023 — NON-FINAL ACTION E-MAILED
- 28 Jun 2023 — SU - NON-FINAL ACTION - WRITTEN
- 02 May 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 01 May 2023 — STATEMENT OF USE PROCESSING COMPLETE